AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2022
Sep 9, 2022
29809_dirs_2022-09-09_808914ab-24bc-4290-b8f7-82128380b550.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2022-09-08
Reporting Person: Johnson Amal M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-08 | Common Stock | M | 6375 | $53.7556 | Acquired | 17599 | Direct |
| 2022-09-08 | Common Stock | S | 6375 | $210.7583 | Disposed | 11224 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-08 | Non-Qualified Stock Option (right to buy) | $53.7556 | M | 6375 | Disposed | 2023-04-25 | Common Stock (6375) | Direct |
Footnotes
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 26, 2023.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $208.23 to $213.36 as follows: 1,665 shares sold at $208.23 - $209.08; 1,300 shares sold at $209.25 - $210.25; 715 shares sold at $210.46 - $210.95; 1,264 shares sold at $211.74 - $212.71; and 1431 shares sold at $212.75 - $213.36. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.